Unknown

Dataset Information

0

IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.


ABSTRACT: Lack of the IL-1 receptor accessory protein (IL-1RAcP) abrogates responses to IL-33 and IL-1 in the mouse thymoma clone EL-4 D6/76 cells. Reconstitution with full-length IL-1RAcP is sufficient to restore responsiveness to IL-33 and IL-1. IL-33 activates IL-1 receptor-associated kinase-1, cJun-N-terminal kinase, and the NF-kappaB pathway in an IL-1RAcP-dependent manner and results in IL-2 release. IL-33 is able to induce the release of proinflammatory cytokines in bone marrow-derived (BMD) mast cells, indicating that IL-33 may have a proinflammatory potential like its relatives IL-1 and IL-18, in addition to its Th2-skewing properties in the adaptive response described previously. Blocking of murine IL-1RAcP with the neutralizing antibody 4C5 inhibits response of mouse thymoma cells and BMD mast cells to IL-33. The interaction of either membrane-bound or soluble forms of IL-1RAcP and IL-33Ralpha-chain depends on the presence of IL-33, as demonstrated by coimmunoprecipitation assays. These data demonstrate that IL-1RAcP is indispensable for IL-33 signaling. Furthermore, they suggest that IL-1RAcP is used by more than one alpha-chain of the IL-1 receptor family and thus may resemble a common beta-chain of that family.

SUBMITTER: Ali S 

PROVIDER: S-EPMC2141833 | biostudies-other | 2007 Nov

REPOSITORIES: biostudies-other

altmetric image

Publications

IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.

Ali Shafaqat S   Huber Michael M   Kollewe Christian C   Bischoff Stephan C SC   Falk Werner W   Martin Michael U MU  

Proceedings of the National Academy of Sciences of the United States of America 20071114 47


Lack of the IL-1 receptor accessory protein (IL-1RAcP) abrogates responses to IL-33 and IL-1 in the mouse thymoma clone EL-4 D6/76 cells. Reconstitution with full-length IL-1RAcP is sufficient to restore responsiveness to IL-33 and IL-1. IL-33 activates IL-1 receptor-associated kinase-1, cJun-N-terminal kinase, and the NF-kappaB pathway in an IL-1RAcP-dependent manner and results in IL-2 release. IL-33 is able to induce the release of proinflammatory cytokines in bone marrow-derived (BMD) mast c  ...[more]

Similar Datasets

| S-EPMC9320129 | biostudies-literature
| S-EPMC5538185 | biostudies-literature
| S-EPMC2491487 | biostudies-literature
| S-EPMC6588585 | biostudies-literature
| S-EPMC3782850 | biostudies-literature
| S-EPMC6330164 | biostudies-literature
| S-EPMC9996901 | biostudies-literature
| S-EPMC3879547 | biostudies-literature
| S-EPMC4813659 | biostudies-literature
| S-EPMC9502846 | biostudies-literature